Impact of dermatologic adverse events induced by targeted therapies on quality of life. Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.. Crit Rev Oncol Hematol. 2016; 158-68: p.158-68. doi:10.1016/j.critrevonc.2016.03.003 10.1016/j.critrevonc.2016.03.003. Epub 2016 Mar 5.Article
Oncostat